FirmLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 13, 2026, FDA's public records list BASF and its 1 subsidiaries with 5 drug applications, 1 drug recall and 1 510(k) clearance. The most recent is a drug recall dated Nov 17, 2020: Kollidon CL-M Crospovidone Ph.Eur.Type B, USP/NF, JP, micronized, packaged in 30 kg plas….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, BASF and its 1 subsidiaries
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Nov 17, 2020 | Kollidon CL-M Crospovidone Ph.Eur.Type B, USP/NF, JP, micronized, packaged in 30 kg plastic drums, Manufacturer: BASF SE, Carl-Bosch-Strabe Class II · Cross contamination: the excipient was found to be contaminated with theophylline. | Drug recalls |
| Aug 28, 2012 | ENLUXTRA HUMIFIBER WOUND DRESSINGK122297 · FRO | 510(k) clearances |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
